Novartis Ag

Alcon, Inc.

Costin Eugene Curatu

Mutlu Karakelle

Xin Hong

Xiaoxiao Zhang

Yueai Liu

Krishnakumar Venkateswaran

John Alfred Campin

Nicholas James Wooder

Myoung-Taek Choi

Xin Wei

Daniel Robert Carson

Rita Stella

Luis Diaz-Santana

Samuel Pollock

Disclosed herein is an implantable accommodative IOL system for insertion into an eye of a patient, the system comprising: an optical element and a housing including an opaque frame. The optical element comprises an optical lens having variable optical power, and the opaque frame is circumferentially disposed around a periphery of the optical element.

Accommodating intraocular lens devices, systems, and methods using an opaque frame

An ophthalmic lens includes an optical filter operable to filter out at least visible light having a wavelength less than 450 nm. The lens also includes a first diffractive structure adapted to produce a focus for visible light in a first wavelength range above 550 nm and to reduce longitudinal chromatic aberration to less than one diopter for incoming visible light in the first wavelength range. The lens also includes a second diffractive structure outside the first diffractive structure in a radial direction and adapted to produce a focus for visible light in a second wavelength range between 450 nm and 550 nm. The second diffractive structure is also adapted to reduce longitudinal chromatic aberration for incoming visible light in the second wavelength range to less than one diopter while allowing longitudinal chromatic aberration in the first wavelength range in an amount greater than the first diffractive structure.

IOL with varying correction of chromatic aberration

Growing community of inventors

Crowley, TX, United States of America

Costin Eugene Curatu